Access to high-cost medicines in New Zealand

Louise Curley; Maree Jensen; Zaheer-Ud-Din Babar; Sanya Ram

doi:10.1016/B978-0-12-811945-7.00012-9

Access to high-cost medicines in New Zealand

Louise Curley, Maree Jensen, Zaheer-Ud-Din Babar, Sanya Ram

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.

Original language	English
Title of host publication	Equitable Access to High-Cost Pharmaceuticals
Editors	Zaheer-Ud-Din Babar
Publisher	Elsevier
Chapter	12
Pages	183-197
Number of pages	15
Edition	1st
ISBN (Electronic)	9780128119624
ISBN (Print)	9780128119457
DOIs	https://doi.org/10.1016/B978-0-12-811945-7.00012-9
Publication status	Published - 21 Feb 2018

Access to Document

10.1016/B978-0-12-811945-7.00012-9Licence: Unspecified

https://www.sciencedirect.com/science/article/pii/B9780128119457000129Licence: Other

Cite this

@inbook{6dee633bbbd841d1a55769a6a7ad51fe,

title = "Access to high-cost medicines in New Zealand",

abstract = "This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency{\textquoteright}s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.",

keywords = "Access to medicines, Funding, High-cost medicines, New Zealand, Pharmaceutical Management Agency of New Zealand, Reimbursement",

author = "Louise Curley and Maree Jensen and Zaheer-Ud-Din Babar and Sanya Ram",

year = "2018",

month = feb,

day = "21",

doi = "10.1016/B978-0-12-811945-7.00012-9",

language = "English",

isbn = "9780128119457",

pages = "183--197",

editor = "Zaheer-Ud-Din Babar",

booktitle = "Equitable Access to High-Cost Pharmaceuticals",

publisher = "Elsevier",

address = "Netherlands",

edition = "1st ",

}

TY - CHAP

T1 - Access to high-cost medicines in New Zealand

AU - Curley, Louise

AU - Jensen, Maree

AU - Babar, Zaheer-Ud-Din

AU - Ram, Sanya

PY - 2018/2/21

Y1 - 2018/2/21

N2 - This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.

AB - This chapter presents an overview of access pathways to high-cost medicines in New Zealand. It describes the avenues via the Pharmaceutical Management Agency’s (PHARMAC) access schemes and also avenues via non-PHARMAC mechanisms.

KW - Access to medicines

KW - Funding

KW - High-cost medicines

KW - New Zealand

KW - Pharmaceutical Management Agency of New Zealand

KW - Reimbursement

UR - https://www.elsevier.com/books/equitable-access-to-high-cost-pharmaceuticals/babar/978-0-12-811945-7

UR - https://www.scopus.com/pages/publications/85054223992

U2 - 10.1016/B978-0-12-811945-7.00012-9

DO - 10.1016/B978-0-12-811945-7.00012-9

M3 - Chapter

SN - 9780128119457

SP - 183

EP - 197

BT - Equitable Access to High-Cost Pharmaceuticals

A2 - Babar, Zaheer-Ud-Din

PB - Elsevier

ER -

Access to high-cost medicines in New Zealand

Abstract

Access to Document

Other files and links

Fingerprint

Cite this